INS and obesity due to melanocortin 4 receptor deficiency: A meta-analysis of 27 randomized controlled trials involving 1278 participants showed that KDs significantly reduce body weight, BMI, triglycerides, blood glucose, insulin, and diastolic blood pressure, suggesting metabolic benefits for obesity and cardiovascular risk.